Bioresorbable scaffolds (BRS) were developed as an alternative to drug-eluting stents (DES) to facilitate vessel restoration and reduce the risk of future adverse events, but problems regarding safety and effectiveness of first-generation BRS have restricted their clinical use.
The bioresorbable coronary scaffolds market is driving due to the factors such as increasing number of coronary artery diseases, and rising demand for biocompatible coronary stents. However, challenges with respect to selection of scaffold material and long duration for the degradation of material is likely to hamper the growth of the market to a certain extent.
The "Bioresorbable coronary scaffolds Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of bioresorbable coronary scaffolds market with detailed market segmentation by product type, material, and end user. The bioresorbable coronary scaffolds market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in bioresorbable coronary scaffolds market and offers key trends and opportunities in the market.
The bioresorbable coronary scaffolds market is segmented on the basis of product type, material, and end user. Based on product type, the market is segmented into drug eluting coronary scaffolds, everolimus-eluting device (absorb gt1), novolimus-eluting device (desolve), sirolimus-eluting device, and paclitaxel-eluting device. Based on material, the market is segmented into polyglycolic acid (PGA) polymers, polyglycolide polymers, and bioresorbable magnesium. On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, and coronary catheterization labs.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the bioresorbable coronary scaffolds market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The bioresorbable coronary scaffolds market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting bioresorbable coronary scaffolds market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the bioresorbable coronary scaffolds market in these regions.
Get more information on this report :
The report covers key developments in the bioresorbable coronary scaffolds market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from bioresorbable coronary scaffolds market are anticipated to have lucrative growth opportunities in the future with the rising demand for bioresorbable coronary scaffolds in the global market. Below mentioned is the list of few companies engaged in the bioresorbable coronary scaffolds market.
The report also includes the profiles of key players in bioresorbable coronary scaffolds market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
Amaranth Medical, Inc.
REVA Medical, Inc.
Abbott Vascular Inc.
Elixir Medical Corporation
Boston Scientific Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
The List of Companies
1. Amaranth Medical, Inc.
2. REVA Medical, Inc.
3. Abbott Vascular Inc.
4. Elixir Medical Corporation
5. BIOTRONIK, Inc.
7. Boston Scientific Corporation
8. Lombard Medical
9. Terumo Corporation
10. KYOTO MEDICAL